id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2026-N-4162-0001,FDA,FDA-2026-N-4162,"Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public
Docket; Request for Comments—Safety and Effectiveness of MFLUSIVA (Influenza Vaccine, mRNA) Manufactured by Moderna TX Inc.",Notice,Request for Comments,2026-05-22T04:00:00Z,2026,5,2026-05-22T04:00:00Z,2026-06-18T03:59:59Z,2026-06-18T09:00:28Z,2026-10321,0,0,09000064b92ecd0e